Phase I evaluation of a fully human ant-{alpha}v integrin monoclonal antibody (CNTO 95) in patients with advanced solid tumours

SA Mullamitha; NC Ton; GJ Parker; A Jackson; PJ Julyan; C Roberts; GA Buonaccorsi; Y Watson; K Davies; S Cheung; JW Valle; L Hope; JA Radford; J Lawrance; MP Saunders; MC Munteanu; MT Nakada; JA Nemeth; HM Davis; Q Jiao; U Prabhaker; Z Lang; RE Corringham; RA Beckman; GC Jayson

Phase I evaluation of a fully human ant-{alpha}v integrin monoclonal antibody (CNTO 95) in patients with advanced solid tumours

SA Mullamitha, NC Ton, GJ Parker, A Jackson, PJ Julyan, C Roberts, GA Buonaccorsi, Y Watson, K Davies, S Cheung, JW Valle, L Hope, JA Radford, J Lawrance, MP Saunders, MC Munteanu, MT Nakada, JA Nemeth, HM Davis, Q JiaoU Prabhaker, Z Lang, RE Corringham, RA Beckman, GC Jayson

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	128-135
Number of pages	7
Journal	Clinical Cancer Research
Volume	13
Issue number	2
Publication status	Published - 1 Apr 2007

Cite this

Mullamitha, SA., Ton, NC., Parker, GJ., Jackson, A., Julyan, PJ., Roberts, C., Buonaccorsi, GA., Watson, Y., Davies, K., Cheung, S., Valle, JW., Hope, L., Radford, JA., Lawrance, J., Saunders, MP., Munteanu, MC., Nakada, MT., Nemeth, JA., Davis, HM., ... Jayson, GC. (2007). Phase I evaluation of a fully human ant-{alpha}v integrin monoclonal antibody (CNTO 95) in patients with advanced solid tumours. Clinical Cancer Research, 13(2), 128-135.

@article{3cf6ef599c0841748a4e7053f91cf96b,

title = "Phase I evaluation of a fully human ant-{alpha}v integrin monoclonal antibody (CNTO 95) in patients with advanced solid tumours",

author = "SA Mullamitha and NC Ton and GJ Parker and A Jackson and PJ Julyan and C Roberts and GA Buonaccorsi and Y Watson and K Davies and S Cheung and JW Valle and L Hope and JA Radford and J Lawrance and MP Saunders and MC Munteanu and MT Nakada and JA Nemeth and HM Davis and Q Jiao and U Prabhaker and Z Lang and RE Corringham and RA Beckman and GC Jayson",

year = "2007",

month = apr,

day = "1",

language = "English",

volume = "13",

pages = "128--135",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research",

number = "2",

}

Mullamitha, SA, Ton, NC, Parker, GJ, Jackson, A, Julyan, PJ, Roberts, C, Buonaccorsi, GA, Watson, Y, Davies, K, Cheung, S, Valle, JW, Hope, L, Radford, JA, Lawrance, J, Saunders, MP, Munteanu, MC, Nakada, MT, Nemeth, JA, Davis, HM, Jiao, Q, Prabhaker, U, Lang, Z, Corringham, RE, Beckman, RA & Jayson, GC 2007, 'Phase I evaluation of a fully human ant-{alpha}v integrin monoclonal antibody (CNTO 95) in patients with advanced solid tumours', Clinical Cancer Research, vol. 13, no. 2, pp. 128-135.

TY - JOUR

T1 - Phase I evaluation of a fully human ant-{alpha}v integrin monoclonal antibody (CNTO 95) in patients with advanced solid tumours

AU - Mullamitha, SA

AU - Ton, NC

AU - Parker, GJ

AU - Jackson, A

AU - Julyan, PJ

AU - Roberts, C

AU - Buonaccorsi, GA

AU - Watson, Y

AU - Davies, K

AU - Cheung, S

AU - Valle, JW

AU - Hope, L

AU - Radford, JA

AU - Lawrance, J

AU - Saunders, MP

AU - Munteanu, MC

AU - Nakada, MT

AU - Nemeth, JA

AU - Davis, HM

AU - Jiao, Q

AU - Prabhaker, U

AU - Lang, Z

AU - Corringham, RE

AU - Beckman, RA

AU - Jayson, GC

PY - 2007/4/1

Y1 - 2007/4/1

M3 - Article

SN - 1078-0432

VL - 13

SP - 128

EP - 135

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 2

ER -